Skip to content 
If you’ve typed “ibogaine treatment success rate” into a search bar, you’re probably not after a headline number. You want an honest answer to one question: if I actually do this, what are my real chances of getting better?
Here’s the short version. About 80% of people get real relief from withdrawal after a single treatment, and roughly 30% stay completely abstinent long-term, with a lot more cutting their use down significantly even when they don’t stay fully clean. Your own odds depend heavily on your health going in, how well the clinic screens you, and what you do in the months after.
Let’s get into where those numbers actually come from.
What Counts as “Success” With Ibogaine, Anyway?
Here’s something nobody tells you upfront. Researchers don’t all agree on what “success” even means.
Some studies only count it as a win if you never touch the substance again. Others count a big drop in use, relief from withdrawal, or just feeling more functional day to day. That’s why one study can report “30% abstinent,” and another can say “60% improved,” and both are telling the truth. They’re just measuring different things.
Timeframes matter too. A result that looks great at one month can look pretty different at twelve. Ibogaine tends to hit hardest right at the start, easing withdrawal and lifting depression fast. What happens after that stretches out over months and years, and honestly, a lot of that is on you, not the medicine.
Short-Term vs. Long-Term Outcomes
This is really the heart of it, so let’s break it down the way most people actually live through it: what happens right away, and what happens down the road.
Right after treatment (days to weeks):
- About 80% of people said ibogaine eliminated or drastically reduced their withdrawal symptoms after a single session. That’s from the most cited opioid study we have, a survey of 88 patients treated in Mexico between 2012 and 2015.
- Half of participants reported reduced cravings, and about a quarter said that relief stuck around for at least three months.
- The same study found most people didn’t show drug-seeking behavior in the first 24 to 72 hours after treatment, which matters a lot if you know how brutal early opioid withdrawal usually is.
Longer term (months to years):
- 30% of participants said they never used opioids again after treatment.
- Of that group, over half (54%) stayed abstinent for at least a year, and about a third (31%) made it past two years.
- At the time they were surveyed, 41% of everyone in the study, not just the ones who stayed fully clean, had gone at least six months without using.
- Yes, 70% relapsed at some point. But even in that group, nearly half (48%) said they were using less than before treatment, and another 11% eventually reached full abstinence anyway.
Add it up, and you get something like 59% of everyone in the study either staying abstinent or meaningfully cutting back. That’s not a miracle cure. But for people who’ve already tried methadone, buprenorphine, or a 30-day rehab and didn’t get anywhere close to that, it’s nothing either.
Mental health outcomes look strong too, at least in the short term. A 2024 Stanford Medicine study followed 30 special operations veterans who received ibogaine combined with magnesium, used to protect the heart, at a clinic in Mexico. One month later, they reported an 88% drop in PTSD symptoms, an 87% drop in depression, and an 81% drop in anxiety. Their disability scores fell from “mild to moderate disability” territory down to “no disability.” That study wasn’t about addiction specifically, but it says a lot about ibogaine’s effect on the kind of mental heaviness that keeps people stuck in the first place.
What Factors Actually Move Your Personal Success Rate
Numbers from a study are one thing. What happens to you is another. A few things show up again and again across the research and the real-world reports.
Your physical and mental health going in. Existing heart conditions and certain psychiatric diagnoses can raise your risk or limit how much ibogaine can help. That’s not a reason to panic. It’s a reason to get properly screened before you commit to anything.
What you’re actually trying to quit. Ibogaine has the strongest research behind it for opioids specifically, mostly because of how well it eases withdrawal and cravings. For alcohol, the research base is thinner, though documented case reports are encouraging. If your use has been chaotic or high risk, you’ll likely need more planning and support around the treatment, not less.
How much insight you actually get from the experience. This one surprised me a little when I first came across it. People who walked away from ibogaine with real clarity about why they started using it in the first place tended to do better over time. Ibogaine isn’t only a chemical reset. For a lot of people, it’s also a few hours of unusually honest self-reflection, and what you do with that matters.
What happens after you leave the clinic. This is the one people underestimate the most. Therapy, peer support, and actually changing your environment and routines all move the needle, and not just for ibogaine, for pretty much every kind of addiction recovery. Ibogaine can hand you a window of clarity and reduced craving. Whether that window turns into lasting change is mostly up to what you build during it, not the treatment itself.
One Person’s Story
Why Safety Screening Is Part of the Success Rate, Not Separate From It
Here’s something worth saying plainly. A treatment doesn’t count as “successful” just because someone felt better afterward. It has to mean they came through the process safely too.
Ibogaine carries real cardiac risk, especially at unsupervised or poorly run clinics. That’s not a small caveat; it’s the main reason serious complications have happened in this space at all. A clinic doing this right will put you through an EKG at minimum, often an echocardiogram if anything looks off, a full review of your medications, and close medical monitoring during and after dosing. In the Stanford veteran study, where all of that was handled properly with magnesium support, there were no serious cardiac complications reported, just mild, temporary side effects like headache and nausea.
If a clinic skips the screening or rushes you through it to keep to a schedule, that’s not a shortcut worth taking. That’s a warning sign.
How Does Ibogaine Stack Up Against Other Treatments?
It’s fair to want to know how ibogaine compares to what you might already be considering, whether that’s a 30-day rehab, methadone, or buprenorphine.
The honest answer is that they’re not really the same kind of thing. Methadone and buprenorphine are ongoing, daily treatments that work well for a lot of people over the long haul. Ibogaine is more of a one-time, high-intensity intervention meant to interrupt the cycle and give you a real shot at starting over, sometimes alongside other treatments afterward, not instead of them.
It’s also usually a lot shorter than a traditional rehab stay, often around a week including prep and recovery, and for some people, meaningfully cheaper than a month of inpatient care.
So What’s Your Realistic Success Rate?
If you’re trying to put all of this together for your own decision, think of it in three layers.
- Short term: very high odds of real withdrawal relief and noticeable craving reduction, especially for opioid use.
- Medium term: a solid share of people stay abstinent or significantly cut back for several months, especially with real aftercare in place.
- Long term: roughly a third of people in the best available opioid study stayed fully abstinent past a year, and well over half showed meaningful improvement overall. Relapse is still common, and this is where your own effort matters most.
You don’t need one clean percentage to make this decision. You need a clinic that screens you properly, an honest picture of what the research actually shows, and a plan for what you’ll do with the clarity ibogaine can give you. That combination, not the number by itself, is what determines your outcome.
Frequently Asked Questions
Is ibogaine effective for opioid addiction?
The strongest data we have says yes, at least for short-term relief. About 80% of people in the largest opioid-focused study reported major withdrawal relief after one treatment, and roughly a third stayed fully abstinent a year or more later.
What’s the one-year abstinence rate for ibogaine?
In the 88-patient Mexico study, 30% of participants never used opioids again, and 54% of that group stayed abstinent for at least a year. A broader 41% of all participants reported at least 6 months of continuous abstinence at the time of the survey.
Is ibogaine safe?
It can be, but only with proper medical screening and supervision. Ibogaine carries real cardiac risk, so a legitimate clinic will run an EKG at a minimum before treatment and monitor you closely throughout treatment.
Does ibogaine work for alcohol addiction?
The research base for alcohol is smaller than for opioids, but documented patient accounts describe strong results when treatment is paired with proper screening and real follow-up support.
| Source | URL |
|---|---|
| Ambio Life Sciences | https://ambio.life/blog/success-rates-in-ibogaine-treatment |
| Journal of Psychedelic Studies (Davis et al., 2017, via NCBI/PMC) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157925/ |
| Nature Medicine (Cherian et al., 2024) | https://www.nature.com/articles/s41591-023-02705-w |
| Stanford Medicine News | https://news.stanford.edu/stories/2024/05/ibogaine-ptsd |
| Experience Ibogaine Testimonials | https://www.experienceibogaine.com/testimonials/ |
